Personalized Medicine

Bioclinica Acquires MDDX Research & Informatics Combining Advanced Image Management Cloud Technology with Its Scientific and Medical Imaging Leadership

November 7, 2017

Best-in-class solution ensures sponsors and CROs have global access to efficient, accurate, and scalable medical imaging to drive better data and outcomes DOYLESTOWN, Pa., Nov. 6, 2017 – Bioclinica®, the world-leading provider of scientific-enabled Medical Imaging, eHealth, and patient-centric solutions supporting clinical research, today announces it has acquired Silicon Valley-based MDDX Research & Informatics, adding […]

Facilitating a drug discovery ecosystem: Genestack joins the Milner Therapeutics Institute

October 30, 2017

“As sequencing technology shrinks to the size of a key ring and emerging technologies make it possible to track changes to the genome at single cell level, then all of a sudden genomics data becomes a streaming and wearable dataset,” says Imad Yassin, Vice President of bio data management company Genestack. He is explaining why […]

BioIVT Expands Its Support for Precision Medicine Researchers

October 25, 2017

BioIVT is sponsoring the Powering Precision Health Summit 2017 and showcasing its precision medicine product and services portfolio BioIVT, a leading provider of biospecimens and related services, today announced that it is sponsoring the Powering Precision Health Summit (PPHS) 2017. This conference will bring together leaders in biomarker research and translational medicine to present the […]

Sword and Medexprim : combining clinical and imaging data in big-data research projects

October 12, 2017

Sword Group and Medexprim are partnering in view to offer cancer centers and large hospitals a unified solution to facilitate translational research, combining clinical and imaging data. SWORD GROUP has developed the innovative solution ConSoRe, in partnership with Unicancer, which federates 20 French leading not-for profit private cancer hospitals (« centres de lutte contre le cancer», http://www.unicancer.fr/unicancer) in France.  ConSoRe is an evolved […]

Focus on practical applications is stifling innovation, say 80% of surveyed chemistry professionals

September 27, 2017

Survey also shows a majority believe that expertise in working with digital tools is critical to career advancement  Chemistry is suffering due to its reputation for not being as innovative as other sciences, such as biology and physics, according to a survey of 186 industry professionals, carried out by Elsevier’s Reaxys team. 78% of chemists […]

The Future of RWE Technology-Moving Beyond Rapid Cycle Analytics

August 31, 2017

Rapid-cycle analytic technologies represent an important advance in the pursuit of improved evidence generation practices – but this is only the first step. Learn how RWE technology is evolving through standardization, efficiency, and democratization of data.

Halloran Consulting Group Announces Role as US Regulatory Lead for Curtana Pharmaceuticals’ CT-179 Orphan Drug Designation for the Treatment of Gliomas

August 18, 2017

BOSTON, August 16, 2017 – Halloran Consulting Group, a national consultancy serving biotech, pharma, & medical device companies with clinical, quality and regulatory compliance projects, today announced their role as US regulatory consultants for Curtana Pharmaceuticals. The Food and Drug Administration (FDA) granted orphan drug designation to CT-179, Curtana Pharmaceuticals’ lead Olig2 inhibitor for the […]

Is a shortage of bioinformaticians holding back adoption of precision therapies?

August 7, 2017

Many key scientists lack essential skills in bioinformatics and this is potentially a bottleneck for therapeutic research in big pharma. Dr Misha Kapushesky, CEO of Genestack, will discuss how increasing pressure on bioinformaticians is slowing the pace of discovery in a webinar ‘NGS: New Business Models in Diagnostics and Drug Development’ organised by Frost & […]

A Summit on the Latest Research and Developments in the Emerging Treatment for Cancer – Immunotherapy.

July 20, 2017

A Summit on the Latest Research and Developments in the Emerging Treatment for Cancer – Immunotherapy. Vonlanthen Group of Companies will be hosting the 2nd Annual Cancer Immunotherapy Summit on September 21st – 22nd, 2017 in Vienna, Austria. Because of the success of the 1st Annual Cancer Immunotherapy Summit and the continued viability of immunotherapy […]

Personalized cancer vaccines show glimmers of success

July 6, 2017

Vaccines tailored to match a person’s particular constellation of cancer mutations seem to have fended off tumours in a handful of patients, two small clinical trials show.   The vaccines are described in papers published in Nature on 5 July1, 2. The studies are the first to report that the approach — which is gaining […]

Certara Endows Professorship at the UF College of Pharmacy

June 28, 2017

Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has endowed a professorship at the University of Florida College of Pharmacy’s Center for Pharmacometrics and Systems Pharmacology. The professorship will strengthen the relationship between the college’s academic program and industry to drive innovation and enhance the application of leading-edge […]

Spearheading Stem Cell Innovations At The Stem Cells and Regenerative Medicine Global Summit

June 11, 2017

TORONTO, Canada, June 12, 2017 – Healthcare professionals, researchers and scientists from across research institutes, hospitals, biotechnology and pharmaceutical companies will gather at the inaugural Stem Cells and Regenerative Medicine Global Summit in Toronto, Canada from 25 – 27 September 2017, to discover development progress of stem cell medical treatments as well as to explore […]

Elsevier launches new Reaxys Medicinal Chemistry to facilitate better connections between biological and chemical data

June 6, 2017

Highly intuitive search with the most advanced indexing and extraction of experimental data available will accelerate lead optimization in early drug discovery Elsevier, the information analytics company specializing in science and health, has today released a new version of Reaxys Medicinal Chemistry to improve the discoverability and extraction of relevant chemistry data – more than […]

GeneCentric Therapeutics Appoints Walter M. Capone as Chief Business Officer and Adds Ellen Lubman to Board of Directors as Company Advances Drug Development Platform

June 1, 2017

DURHAM, N.C., May 30, 2017 (GLOBE NEWSWIRE) — GeneCentric Therapeutics, Inc., a precision medicine company dedicated to accelerating drug development by redefining the advanced classification of cancers, today announced the appointments of Walter M. Capone as Chief Business Officer and Ellen Lubman to the company’s Board of Directors.  In his role as CBO, Mr. Capone […]

Researchers gain greater insights into experimental data by leveraging the growing collections of molecular interactions from published literature

May 24, 2017

SolveBio and Elsevier, the information analytics company, have announced a collaboration to integrate the use of Pathway Studio, Elsevier’s database of biological molecular interactions and curated pathways, with SolveBio platform, providing customers with one seamless solution to drive better precision medicine research. Under the terms of the agreement, all licensed SolveBio users will have free […]

FEEDBACK